Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory study (TEMPER study). - Suzuki M; Kishino A; Sugasawa M; Fujii T; Nakanome A; Terada T; Hirakawa H; Ueki Y; Matsuo M; Ito R; Hotomi M; Kanno M; et al. (International journal of clinical oncology, 2026)